Purchases and Sales Made in Q2 2023 in Deciphera Pharmaceuticals, Inc. (DCPH)
This table provides information about the institutional ownership of Deciphera Pharmaceuticals, Inc. (DCPH) during Q2 2023. The information is specifically focused on institutions that hold shares of Deciphera Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-105K- 54.89% |
$1.4M - $1.68M
|
86.5K
$0
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-111K- 47.86% |
$1.47M - $1.77M
|
121K
$0
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-116K- 34.75% |
$1.54M - $1.85M
|
218K
$0
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-153K- 4.6% |
$2.03M - $2.44M
|
3.17M
$0
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-160K- 33.61% |
$2.12M - $2.55M
|
316K
$0
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-219K- 4.75% |
$2.91M - $3.49M
|
4.39M
$0
|
|
Aug 11, 2023
Q2 2023
|
Hillsdale Investment Management Inc.
Toronto, A6 |
SELL
|
- |
-253K- 99.77% |
$3.35M - $4.03M
|
580
$0
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-409K- 51.72% |
$5.43M - $6.53M
|
382K
$0
|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-589K- 98.28% |
$7.83M - $9.41M
|
10.3K
$0
|
|
Aug 14, 2023
Q2 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-704K- 12.6% |
$9.34M - $11.2M
|
4.88M
$0
|
|
Aug 14, 2023
Q2 2023
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-745K- 63.39% |
$9.89M - $11.9M
|
430K
$0
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-934K- 30.54% |
$12.4M - $14.9M
|
2.12M
$0
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-934K- 30.54% |
$12.4M - $14.9M
|
2.12M
$0
|